Communicable diseases (e.g. intestinal protozoa and helminth infections) and non-communicable chronic conditions (e.g. type 2 diabetes and malnutrition) Infections and Infestations
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Willing to participate in the study 2. Be in possession of a written informed consent by a parent/guardian on behalf of the child 3. Not participating in other studies 4. Being a primary school child aged 9-12 years, male or female 5. Absence of ill-health condition (e.g. severe anaemia, respiratory disease or other major illnesses), as assessed by a medical doctor at baseline.
Exclusion criteria
Exclusion criteria: 1. Children below the age of 9 years or above 12 years 2. Not having a written informed consent or no parental/legal guardian?s permission to participate 3. Suffer from medical conditions which prevent participation in the study, as determined by qualified medical personnel 4. Attending other clinical trials during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The prevalence of communicable diseases (e.g. intestinal protozoa and helminth infections) and non-communicable chronic conditions (e.g. type 2 diabetes and malnutrition). 2. Differences (non-infected vs. infected) and changes (before and after treatment) in physical fitness levels, psychosocial health and cognitive performance. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Reduction of infection prevalence and intensity of soil-transmitted helminths and schistosomiasis. 2. Differences and changes in disease-related morbidity measures (malnutrition and anaemia). Treatment will be administered to all study participants directly after baseline assessments, 1 year and 2 years after baseline. Reassessment of parasitic infection, anthropometric and haemoglobin measurements, clinical examination, physical fitness and cognitive performance will take place at the end of the study follow-up, 2 years after baseline. | — |
Countries
South Africa